Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial-Reference-Cited by-同舟云学术

Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial

Published:2016-07 Issue: Volume:32 Page:96-104
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Yang Yang,Ma Lu,Wang Chao,Kong Deyang,Wang YaPing,Mei Changlin

Publisher

Elsevier BV

Subject

Internal Medicine

Reference32 articles.

1. Hepatitis B virus infection;Liaw;Lancet,2009

2. Update on epidemiology of hepatitis B and C in China;Cui;J Gastroenterol Hepatol,2013

3. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations;Johnson;Kidney Int,1990

4. Hepatitis B virus-associated nephropathy;Bhimma;Am J Nephrol,2004

5. Heparin/heparan sulphate interactions with complement—a possible target for reduction of renal function loss?;Zaferani;Nephrol Dial Transplant,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of tacrolimus and entecavir combination therapy in the treatment of hepatitis B virus-associated glomerulonephritis: a multi-center, placebo controlled, and single-blind randomized trial;Annals of Palliative Medicine;2022-05

2. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome;Cochrane Database of Systematic Reviews;2021-11-15

3. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases;Kidney International;2021-10

4. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome;COCHRANE DB SYST REV;2021

5. The Complement C3a and C3a Receptor Pathway in Kidney Diseases;Frontiers in Immunology;2020-08-18